Search results for "TUMORS"

showing 10 items of 1138 documents

Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection

2021

Background: Hepatic resection remains the treatment of choice for patients with early-stage HCC with preserved liver function. Unfortunately, however, the majority of patients develop tumor recurrence. While several clinical factors were found to be associated with tumor recurrence, HCC pathogenesis is a complex process of accumulation of somatic genomic alterations, which leads to a huge molecular heterogeneity that has not been completely understood. The aim of this study is to complement potentially predictive clinical and pathological factors with next-generation sequencing genomic profiling and loss of heterozygosity analysis. Methods: 124 HCC patients, who underwent a primary hepatic …

Cancer Researchmedicine.medical_specialtyHepatitis C virusSubgroup analysisLower riskmedicine.disease_causelcsh:RC254-282GastroenterologyArticlePathogenesisLoss of heterozygositynext-generation sequencing.03 medical and health sciences0302 clinical medicineInternal medicineMedicinePTENHCCHCC recurrencebiologybusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOncology030220 oncology & carcinogenesisHepatocellular carcinomaliver resectionbiology.proteinnext-generation sequencingloss of heterozygosity030211 gastroenterology & hepatologyLiver functionbusinessCancers
researchProduct

Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients

2021

Purpose: We aimed at assessing the impact of surveillance on long-term survival in HCC patients. Methods: From the ITA.LI.CA database, we selected 1028 cases with long (≥5 years, LS group) and 2721 controls with short-term survival (&lt

Cancer Researchmedicine.medical_specialtyHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIACancer stageIndependent predictorLogistic regressionlcsh:RC254-282Article03 medical and health sciencesLong-term survival0302 clinical medicineInternal medicineLong term survivalmedicineTreatment.Surveillancebusiness.industryCancer stageSettore MED/09 - MEDICINA INTERNAConfoundingmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensTreatmentCancer stage; Hepatocellular carcinoma; Long-term survival; Surveillance; TreatmentOncology030220 oncology & carcinogenesisHepatocellular carcinomaBaseline characteristics030211 gastroenterology & hepatologybusiness
researchProduct

Identification of High-Risk Atypical Meningiomas According to Semantic and Radiomic Features

2020

Up to 60% of atypical meningiomas (World Health Organization (WHO) grade II) reoccur within 5 years after resection. However, no clear radiological criteria exist to identify tumors with higher risk of relapse. In this study, we aimed to assess the association of certain radiomic and semantic features of atypical meningiomas in MRI with tumor recurrence. We identified patients operated on primary atypical meningiomas in our department from 2007 to 2017. An analysis of 13 quantitatively defined radiomic and 11 qualitatively defined semantic criteria was performed based on preoperative MRI scans. Imaging characteristics were assessed along with clinical and survival data. The analysis include…

Cancer Researchmedicine.medical_specialtyMultivariate analysisTumor resectionlcsh:RC254-282survivalArticleWorld healthResection03 medical and health sciences0302 clinical medicineatypical meningiomamedicineUnivariate analysisbusiness.industryHazard ratiopredictionOdds ratiolcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensConfidence intervalOncologyradiomics030220 oncology & carcinogenesisRadiologybusiness030217 neurology & neurosurgeryCancers
researchProduct

Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index

2021

The novel CRP–albumin–lymphocyte (CALLY) index is an improved immunonutritive scoring system, based on serum C-reactive protein (CRP), serum albumin, and the lymphocyte count. It has shown promise as a prognostic index for patients with hepatocellular carcinoma (HCC) undergoing resections. This study evaluated the prognostic ability of the CALLY index for patients with HCC undergoing transarterial chemoembolization (TACE). We retrospectively identified 280 treatment-naïve patients with HCC that underwent an initial TACE at our institution, between 2010 and 2020. We compared the CALLY index to established risk factors in univariate and multivariate regression analyses for associations with m…

Cancer Researchmedicine.medical_specialtyMultivariate statisticsIndex (economics)Scoring systemFuture studiesMultivariate analysistransarterial chemoembolizationGastroenterologyArticlerisk predictionInternal medicinemedicineOverall survivalRC254-282inflammation indexbusiness.industryfungiUnivariateNeoplasms. Tumors. Oncology. Including cancer and carcinogenshepatocellular carcinomamedicine.diseaseCRP–albumin–lymphocyte ratioimmunoscoringOncologyHepatocellular carcinomabusinessCancers
researchProduct

Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Control…

2021

ObjectivesThe Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score are immunonutritive scoring systems with proven predictive ability in various cancer entities, including hepatocellular carcinoma (HCC). We performed the first evaluation of the CONUT score for patients undergoing transarterial chemoembolization (TACE) and compared CONUT and PNI in the ability to predict median overall survival (OS).MethodsBetween 2010 and 2020, we retrospectively identified 237 treatment-naïve patients with HCC who underwent initial TACE at our institution. Both scores include the albumin level and total lymphocyte count. The CONUT additionally includes the cholesterol level. …

Cancer Researchmedicine.medical_specialtyMultivariate statisticsMultivariate analysisSubgroup analysistransarterial chemoembolizationimmunonutritive scoringGastroenterology03 medical and health sciences0302 clinical medicinecontrolling nutritional statusInternal medicinemedicineIn patientsurvival predictionRC254-282Original Researchrisk scoringbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerNutritional statushepatocellular carcinomaprognostic nutritional indexmedicine.diseaseBCLC StageOncology030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologybusinessFrontiers in Oncology
researchProduct

The prevalence and characteristics of breakthrough cancer pain in patients receiving low doses of opioids for background pain

2021

Simple Summary The aim of this study was to assess the prevalence and characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain. This prospective study showed that in this population, BTcP prevalence was 69.8%. Many patients did not achieve a sufficient level of satisfaction with BTcP medications, particularly with oral morphine. Data also suggest that better optimization of background analgesia, though apparently acceptable, may limit the number of BTcP episodes. Abstract The aim of this study was to assess the prevalence and characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background p…

Cancer Researchmedicine.medical_specialtyPain relieflcsh:RC254-282ArticleCONSECUTIVE SAMPLE03 medical and health sciences0302 clinical medicineAnalgesic therapyInternal medicineEpidemiologymedicineIn patientOral morphinebreakthrough cancer pain; opioids; dosesbusiness.industryLow doseBreakthrough cancer painlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdosesOpioidsOncologyDose030220 oncology & carcinogenesisCancer painbusiness030217 neurology & neurosurgery
researchProduct

Episodic Breathlessness with and without Background Dyspnea in Advanced Cancer Patients Admitted to an Acute Supportive Care Unit

2020

Aim: To characterize episodic breathlessness (EB) in patients with advanced cancer, and to determine factors influencing its clinical appearance. Methods: A consecutive sample of advanced cancer patients admitted to an acute palliative care unit was surveyed. Continuous dyspnea and EB were measured by a numerical scale. The use of drugs used for continuous dyspnea and EB was recorded. Patients were asked about the characteristics of EB (frequency, intensity, duration and triggers). The Multidimensional dyspnea profile (MDP), the Brief dyspnea inventory (BDI), the Athens sleep scale (AIS) and the Hospital Anxiety and Depression Scale (HADS) were also administered. Results: From 439 advanced …

Cancer Researchmedicine.medical_specialtyPalliative careEpisodic breathlessneOpioidHospital Anxiety and Depression Scalelcsh:RC254-282ArticleCONSECUTIVE SAMPLE03 medical and health sciences0302 clinical medicineInternal medicineMedicineadvanced cancerIn patient030212 general & internal medicinepalliative carebusiness.industryopioidsClinical appearancedyspneaPalliative care.lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensAdvanced cancerConfidence intervalrespiratory tract diseasesepisodic breathlessnessOncology030220 oncology & carcinogenesisbusinessCancers
researchProduct

Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review.

1997

Renal oncocytomas comprise a cytogenetically heterogeneous group of tumors consisting potentially of cytogenetic distinguishable subgroups. Review of the literature revealed loss of chromosome 1 and Y as a possible anomaly for at least one subset of oncocytomas. The frequent finding of rearrangements involving chromosome 11 band q13 characterizes another subset of oncocytomas. We report the cytogenetic and pathological features of a renal oncocytoma diagnosed in a 72-year-old woman and found a t(9;11)(p23;q13) as a consistent abnormality. This supports the idea that translocations involving 11q13 define a further subset of oncocytoma. (C) Elsevier Science Inc., 1997.

Cancer Researchmedicine.medical_specialtyPathologyChromosomes Human Pair 21Chromosomes Human Pair 20Chromosomal translocationChromosome DisordersBiologyurologic and male genital diseasesTranslocation GeneticGeneticsmedicineAdenoma OxyphilicHumansOncocytomaRenal oncocytomaCYTOGENETIC ABNORMALITIESMolecular BiologyAgedGeneticsChromosome AberrationsChromosomes Human Pair 11CytogeneticsChromosomeLOCALIZATIONKaryotypemedicine.diseaseTUMORSGENEKidney NeoplasmsChromosome BandingChromosomal regionFemaleAbnormalityChromosomes Human Pair 9Cancer genetics and cytogenetics
researchProduct

Preoperative CT-Based Deep Learning Model for Predicting Risk Stratification in Patients With Gastrointestinal Stromal Tumors.

2021

ObjectiveTo develop and evaluate a deep learning model (DLM) for predicting the risk stratification of gastrointestinal stromal tumors (GISTs).MethodsPreoperative contrast-enhanced CT images of 733 patients with GISTs were retrospectively obtained from two centers between January 2011 and June 2020. The datasets were split into training (n = 241), testing (n = 104), and external validation cohorts (n = 388). A DLM for predicting the risk stratification of GISTs was developed using a convolutional neural network and evaluated in the testing and external validation cohorts. The performance of the DLM was compared with that of radiomics model by using the area under the receiver operating char…

Cancer Researchmedicine.medical_specialtyReceiver operating characteristicbusiness.industryDeep learningClass activation mappingNeoplasms. Tumors. Oncology. Including cancer and carcinogensrisk assessmentdeep learningX-ray computedtomographyConfidence intervalprediction modelgastrointestinal stromal tumorsOncologyRisk stratificationCohortMedicineIn patientRadiologyArtificial intelligencebusinessRisk assessmentRC254-282Original ResearchFrontiers in oncology
researchProduct

Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe

2020

Purpose Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. Methods Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health–funded organization. Responses were analyzed to measure trends and regional subtleties about patient oncofertility experiences and to analyze barriers to care at sites that provide oncofertility services. Results Sixty-three res…

Cancer Researchmedicine.medical_specialtyReferralmedia_common.quotation_subjectBest practiceMEDLINEFertilitylcsh:RC254-282Cost EffectivenessFertilidade03 medical and health sciences0302 clinical medicineSupportive Care and Quality of LifeJournal ArticleQuality of CareMedicineFertility preservationmedia_commonOncofertilityEthicsMedicine(all)Response rate (survey)030219 obstetrics & reproductive medicinebusiness.industryHealth Services and OutcomesORIGINAL REPORTSlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSupportive CarePolicy AnalysisWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthFertilityOncology030220 oncology & carcinogenesisFamily medicineScale (social sciences)Quality of Life/dk/atira/pure/researchoutput/pubmedpublicationtype/D016428business
researchProduct